Evidence map›Paper›PMID 40313554›Full record

ArticleFrontiers in medicine2025

Distinct immunological signatures define three sepsis recovery trajectories: a multi-cohort machine learning study.

Rui Zhang, Fang Long, Jingyi Wu, Ruoming Tan

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Parallel single-cell host immune profiling and pathogen genomic characterization inFrontiers in cellular and infection microbiology · 2026
    Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rui Zhang *Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fang Long *Department of Critical Care Medicine, Zhuzhou Lukou District People's Hospital, Zhuzhou, Hunan, China.
Jingyi Wu *Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ruoming TanDepartment of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Understanding heterogeneous recovery patterns in sepsis is crucial for personalizing treatment strategies and improving outcomes. Objective: To identify distinct recovery trajectories in sepsis and develop a prediction model using early clinical and immunological markers. Design setting and participants: Retrospective cohort study using data from 28,745 adult patients admitted to 12 intensive care units (ICUs) with sepsis between January 2014 and December 2024. Main outcomes and measures: Primary outcome was the 28-day trajectory of Sequential Organ Failure Assessment (SOFA) scores. Secondary outcomes included 90-day mortality and hospital length of stay. Results: Among 24,450 eligible patients (mean [SD] age, 64.5 [15.3] years; 54.2% male), three distinct recovery trajectories were identified: rapid recovery (42.3%), slow recovery (35.8%), and deterioration (21.9%). The machine learning model achieved an AUROC of 0.85 (95% CI, 0.83-0.87) for trajectory prediction. Key predictors included initial SOFA score, lactate levels, and inflammatory markers. Mortality rates were 12.3, 28.7, and 45.6% for rapid, slow, and deterioration groups, respectively. Conclusions and relevance: Early prediction of sepsis recovery trajectories is feasible and may facilitate personalized treatment strategies. The developed model could assist clinical decision-making and resource allocation in critical care settings.

Indexed as

critically illimmunological signaturesmachine learningrecovery trajectorysepsis

Identifiers

PMID40313554
PMCPMC12045099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.